EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Danicamtiv increases cardiac mechanical efficiency

Trent Meehan, Toan Pham iD, Kenneth Tran iD, Andrew J Taberner iD, June-Chiew Han iD

The Journal of Physiology · 2025

DOI: 10.1113/jp288913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, 2025. Verfasst von Trent Meehan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Myosins, Myocardium, Heart, Cardiotonic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Heart Foundation of New Zealand, minhealthnz | Health Research Council of New Zealand (HRC), Royal Society of New Zealand | Marsden Fund (Royal Society of New Zealand Marsden Fund).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Danicamtiv is a recently developed cardiac‐specific myosin activator that directly increases actomyosin interaction and, thereby, increases force. It is currently studied pre‐clinically and has entered clinical trials. In this study, we provide the first assessment of its effects on cardiac energetics. Ventricular trabeculae from rats were isolated and studied in vitro . Each trabecula was stimulated to produce twitch force over ranges of muscle lengths and afterloads, with muscle heat output simultaneously measured. Each trabecula was superfused with and without danicamtiv (5 µM). In both interventions, muscles were required to undergo both isometric and work‐loop contraction protocols to quantify the components of heat output – that from muscle contraction, that from intracellular Ca 2+ cycling and that from actomyosin cross‐bridge cycling. Danicamtiv was found to increase twitch force, muscle heat and cross‐bridge heat, with no effect on the energy expenditure associated with intracellular Ca 2+ cycling. Danicamtiv slowed isometric twitch force kinetics and slowed shortening kinetics. Danicamtiv increased the extent of muscle shortening, increased muscle work output and increased mechanical efficiency, while preserving cross‐bridge efficiency. In conclusion, danicamtiv increases mechanical efficiency, the mechanism of which arises from the greater increase of force and muscle shortening that increase mechanical work than the increase of heat. The relative smaller increase of heat is due to a null effect of danicamtiv on the energy for intracellular Ca 2+ cycling. Our results provide perspective for the utility of danicamtiv as an inotropic agent not only for mechanical enhancement but also for energetic enhancement in increasing mechanical efficiency. image Key points Clinical trials are presently exploring the potential of a new myotrope, danicamtiv, to improve cardiac mechanics by increasing muscle force output. A range of active pre‐clinical research is likewise uncovering the biophysical mechanism of how danicamtiv affects cardiac mechanics, increases cardiac force and slows contractile kinetics. This study provides the first energetic assessment of danicamtiv by measuring muscle heat output, and shows that danicamtiv increases cardiac energy efficiency. The mechanism of the increased efficiency resides in the increase of muscle force–length work greater than the increase of muscle heat. This study demonstrates that danicamtiv is a cardiac myotrope that not only enhances mechanics, but also exerts its enhancement effect on energetics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyosinsMyocardiumHeartCardiotonic AgentsActomyosinAnimalsRatsCalcium SignalingMaleMyocardial Contraction

Stichwörter der Autor:innen

cardiac energeticscross‐bridge efficiencyheatmyosin activatorwork‐loop contraction

Substanzen

MyosinsActomyosinCardiotonic Agents

Autor:innen und Institutionen

  • Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.
  • Department of Engineering Science and Biomedical Engineering, The University of Auckland, Auckland, New Zealand.

ORCID-Profile: Toan Pham, Kenneth Tran, Andrew J Taberner, June-Chiew Han

Förderung

  • National Heart Foundation of New Zealand
  • minhealthnz | Health Research Council of New Zealand (HRC)
  • Royal Society of New Zealand | Marsden Fund (Royal Society of New Zealand Marsden Fund)

Zitieren

APA

Meehan, T., Pham, T., Tran, K., Taberner, A. J., & Han, J. C. (2025). Danicamtiv increases cardiac mechanical efficiency. The Journal of Physiology. https://doi.org/10.1113/jp288913

Vancouver

Meehan T, Pham T, Tran K, Taberner AJ, Han JC. Danicamtiv increases cardiac mechanical efficiency. The Journal of Physiology. 2025. doi:10.1113/jp288913

BibTeX
@article{Meehan2025,
  author = {Meehan, Trent and Pham, Toan and Tran, Kenneth and Taberner, Andrew J and Han, June-Chiew},
  title = {Danicamtiv increases cardiac mechanical efficiency},
  journal = {The Journal of Physiology},
  year = {2025},
  doi = {10.1113/jp288913}
}
Kostenlos starten →